✦ LIBER ✦

PMS29 CANADIAN COST-EFFECTIVENESS ANALYSIS OF ABATACEPT (ORENCIA™) FOR THE MANAGEMENT OF MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS IN PATIENTS WITH INADEQUATE RESPONSE TO METHOTREXATE

✍ Scribed by D Zou; O Desjardins; N Tsao; R Goeree

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS18 COST-EFFECTIVENESS OFABATACEPT IN

✍ MR Alves; F Carvalho Jr; G Litalien 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

PMS29 Abatacept or Infliximab for Patien

✍ M. Benucci; W. Stam; I. Gilloteau; D. Crocchiolo; K. Sennfält; A. Leclerc; N. Be 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PMS9 COST-EFFECTIVENESS OF ABATACEPT IN

✍ M Maier-Moldovan; Y Yuan; R Maclean; GJ L'Italien 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

PMS37 THE COST-EFFECTIVENESS OF ABATACEP

✍ M Lebmeier; L Pericleous; P Drost; P Dequen; M Ouwens; G Bergman; H Baig 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PMS14 A COST-EFFECTIVENESS ANALYSIS OF B

✍ PK Gandhi; JJ Spooner; P Viraparia; TL Kauf 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

PMS35 Cost-Effectiveness of Tocilizumab

✍ I. Ertenli 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB